Federal Register / Vol. 90, No. 8 / Tuesday, January 14, 2025 / Notices 3213 

6The maximum penalty amount is per day, 

unless otherwise indicated. 

7 12 U.S.C. 1464(v) provides the maximum CMP 

amounts for the late filing of certain Call Reports. 

In 2012, however, the FDIC issued regulations that 

further subdivided these amounts based upon the 

size of the institution and the lateness of the filing. 

See 77 FR 74573, 74576 through 78 (Dec. 17, 2012), 

codified at 12 CFR 308.132(e)(1). These adjusted 

subdivided amounts are found at the end of this 

chart. 

8The maximum penalty amount for an institution 

is the lesser of this amount or 1 percent of total 

assets. 

9 12 U.S.C. 1817(a) provides the maximum CMP 

amounts for the late filing of certain Call Reports. 

In 1991, however, the FDIC issued regulations that 

further subdivided these amounts based upon the 

size of the institution and the lateness of the filing. 

See 56 FR 37968, 37992–93 (Aug. 9, 1991), codified 

at 12 CFR 308.132(e)(1). These adjusted subdivided 

amounts are found at the end of this chart. 

10The maximum penalty amount for an 

institution is the lesser of this amount or 1 percent 

of total assets. 

Continued 

MAXIMUM CIVIL MONEY PENALTY AMOUNTS—Continued 

U.S. Code citation 

Current maximum 

CMP 

(through January 

14, 2025) 

Adjusted 

maximum 

CMP6

(beginning January 15, 2025) 

For assessments < $10,000 ................................................................................................................. 153 157 

12 U.S.C. 1829b(j) ....................................................................................................................................... 25,597 26,262 

12 U.S.C. 1832(c) ........................................................................................................................................ 3,558 3,650 

12 U.S.C. 1884 ............................................................................................................................................ 356 365 

12 U.S.C. 1972(2)(F) 

Tier One CMP ...................................................................................................................................... 12,249 12,567 

Tier Two CMP ...................................................................................................................................... 61,238 62,829 

Tier Three CMP16 ................................................................................................................................ 2,449,575 2,513,215 

12 U.S.C. 3909(d) ........................................................................................................................................ 3,047 3,126 

15 U.S.C. 78u–2 

Tier One CMP (individuals) .................................................................................................................. 11,524 11,823 

Tier One CMP (others) ......................................................................................................................... 115,231 118,225 

Tier Two CMP (individuals) .................................................................................................................. 115,231 118,225 

Tier Two CMP (others) ......................................................................................................................... 576,158 591,127 

Tier Three CMP (individuals) ............................................................................................................... 230,464 236,451 

Tier Three CMP (others) ...................................................................................................................... 1,152,314 1,182,251 

15 U.S.C. 1639e(k) 

First violation ........................................................................................................................................ 14,069 14,435 

Subsequent violations .......................................................................................................................... 28,135 28,866 

31 U.S.C. 3802 ............................................................................................................................................ 13,946 14,308 

42 U.S.C. 4012a(f) ....................................................................................................................................... 2,661 2,730 

CFR Citation Current presumptive CMP 

(through January 14, 2025) 

Adjusted presumptive CMP 

(beginning January 15, 2025) 

12 CFR 308.132(e)(1)(i) 

Institutions with $25 million or more in assets.

1 to 15 days late ....................................................................... $672 ............................................... $689. 

16 or more days late ................................................................. $1,344 ............................................ $1,379. 

Institutions with less than $25 million in assets.

1 to 15 days late 17 ................................................................... $225 ............................................... $231. 

16 or more days late 18 ............................................................. $447 ............................................... $459. 

12 CFR 308.132(e)(1)(ii) 

Institutions with $25 million or more in assets.

1 to 15 days late ....................................................................... $1,119 ............................................ $1,148. 

16 or more days late ................................................................. $2,238 ............................................ $2,296. 

Institutions with less than $25 million in assets.

1 to 15 days late ....................................................................... 1/50,000th of the institution’s total 

assets.

1/50,000th of the institution’s total 

assets. 

16 or more days late ................................................................. 1/25,000th of the institution’s total 

assets.

1/25,000th of the institution’s total 

assets. 

12 CFR 308.132(e)(2) ............................................................................. $48,992 .......................................... $50,265. 

12 CFR 308.132(e)(3) 

Tier One CMP .................................................................................. $4,899 ............................................ $5,026. 

Tier Two CMP .................................................................................. $48,992 .......................................... $50,265. 

Tier Three CMP19 ............................................................................ $2,449,575 ..................................... $2,513,215. 

Federal Deposit Insurance Corporation. 

Dated at Washington, DC on January 8, 

2025. 

Debra A. Decker, 

Executive Secretary. 

[FR Doc. 2025–00643 Filed 1–13–25; 8:45 am] 

BILLING CODE 6714–01–P 

FEDERAL RESERVE SYSTEM 

Formations of, Acquisitions by, and 

Mergers of Bank Holding Companies 

The companies listed in this notice 

have applied to the Board for approval, 

pursuant to the Bank Holding Company 

Act of 1956 (12 U.S.C. 1841 et seq.) 

(BHC Act), Regulation Y (12 CFR part 

225), and all other applicable statutes 

and regulations to become a bank 

holding company and/or to acquire the 

assets or the ownership of, control of, or 

the power to vote shares of a bank or 

bank holding company and all of the 

banks and nonbanking companies 

owned by the bank holding company, 

including the companies listed below. 


khammond on DSK9W7S144PROD with NOTICES
3214 Federal Register / Vol. 90, No. 8 / Tuesday, January 14, 2025 / Notices 

11The maximum penalty amount for an 

institution is the lesser of this amount or 1 percent 

of total assets. 

12The maximum penalty amount for an 

institution is the lesser of this amount or 1 percent 

of total assets. 

13These amounts also apply to CMPs in statutes 

that cross-reference 12 U.S.C. 1818, such as 12 

U.S.C. 2601, 2804(b), 3108(b), 3349(b), 4009(a), 

4309(a), 4717(b); 15 U.S.C. 1607(a), 1681s(b), 

1691(b), 1691c(a), 1693o(a); and 42 U.S.C. 3601. 

14The maximum penalty amount for an 

institution is the lesser of this amount or 1 percent 

of total assets. 

15The $157-per-day maximum CMP under 12 

U.S.C. 1828(h) for failure or refusal to pay any 

assessment applies only when the assessment is 

less than $10,000. When the amount of the 

assessment is $10,000 or more, the maximum CMP 

under section 1828(h) is 1 percent of the amount 

of the assessment for each day that the failure or 

refusal continues. 

16The maximum penalty amount for an 

institution is the lesser of this amount or 1 percent 

of total assets. 

17The maximum penalty amount for an 

institution is the greater of this amount or 1/ 

100,000th of the institution’s total assets. 

18The maximum penalty amount for an 

institution is the greater of this amount or 1/ 

50,000th of the institution’s total assets. 

19The maximum penalty amount for an 

institution is the lesser of this amount or 1 percent 

of total assets. 

The public portions of the 

applications listed below, as well as 

other related filings required by the 

Board, if any, are available for 

immediate inspection at the Federal 

Reserve Bank(s) indicated below and at 

the offices of the Board of Governors. 

This information may also be obtained 

on an expedited basis, upon request, by 

contacting the appropriate Federal 

Reserve Bank and from the Board’s 

Freedom of Information Office at 

https://www.federalreserve.gov/foia/ 

request.htm. Interested persons may 

express their views in writing on the 

standards enumerated in the BHC Act 

(12 U.S.C. 1842(c)). 

Comments received are subject to 

public disclosure. In general, comments 

received will be made available without 

change and will not be modified to 

remove personal or business 

information including confidential, 

contact, or other identifying 

information. Comments should not 

include any information such as 

confidential information that would not 

be appropriate for public disclosure. 

Comments regarding each of these 

applications must be received at the 

Reserve Bank indicated or the offices of 

the Board of Governors, Ann E. 

Misback, Secretary of the Board, 20th 

Street and Constitution Avenue NW, 

Washington DC 20551–0001, not later 

than February 13, 2025. 

A. Federal Reserve Bank of Chicago 

(Colette A. Fried, Assistant Vice 

President) 230 South LaSalle Street, 

Chicago, Illinois 60690–1414. 

Comments can also be sent 

electronically to 

Comments.applications@chi.frb.org: 

1. UIR Acceptance Corporation, 

Lemont, Illinois; to become a bank 

holding company by acquiring Easton 

Bancshares, Inc., and thereby indirectly 

acquiring Community Bank of Easton, 

both of Easton, Illinois. 

Board of Governors of the Federal Reserve 

System. 

Michele Taylor Fennell, 

Associate Secretary of the Board. 

[FR Doc. 2025–00599 Filed 1–13–25; 8:45 am] 

BILLING CODE 6210–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Agency for Healthcare Research and 

Quality 

Supplemental Evidence and Data 

Request on The Performance of Fusion 

Procedures for Degenerative Disease 

of the Lumbar Spine 

AGENCY: Agency for Healthcare Research 

and Quality (AHRQ), HHS. 

ACTION: Request for Supplemental 

Evidence and Data Submission. 

SUMMARY: The Agency for Healthcare 

Research and Quality (AHRQ) is seeking 

scientific information submissions from 

the public. Scientific information is 

being solicited to inform our review on 

The Performance of Fusion Procedures 

for Degenerative Disease of the Lumbar 

Spine, which is currently being 

conducted by the AHRQ’s Evidencebased Practice Centers (EPC) Program. 

Access to published and unpublished 

pertinent scientific information will 

improve the quality of this review. 

DATES: Submission Deadline on or 

before February 13, 2025. 

ADDRESSES: 

Email submissions: epc@

ahrq.hhs.gov. 

Print submissions: 

Mailing Address: Center for Evidence 

and Practice Improvement, Agency for 

Healthcare Research and Quality, 

ATTN: EPC SEADs Coordinator, 5600 

Fishers Lane, Mail Stop 06E53A, 

Rockville, MD 20857 

Shipping Address (FedEx, UPS, etc.): 

Center for Evidence and Practice 

Improvement, Agency for Healthcare 

Research and Quality, ATTN: EPC 

SEADs Coordinator, 5600 Fishers 

Lane, Mail Stop 06E77D, Rockville, 

MD 20857 

FOR FURTHER INFORMATION CONTACT: 

Kelly Carper, Telephone: 301–427–1656 

or Email: epc@ahrq.hhs.gov. 

SUPPLEMENTARY INFORMATION: The 

Agency for Healthcare Research and 

Quality has commissioned the 

Evidence-based Practice Centers (EPC) 

Program to complete a review of the 

evidence for The Performance of Fusion 

Procedures for Degenerative Disease of 

the Lumbar Spine. AHRQ is conducting 

this review pursuant to Section 902 of 

the Public Health Service Act, 42 U.S.C. 

299a. 

The EPC Program is dedicated to 

identifying as many studies as possible 

that are relevant to the questions for 

each of its reviews. In order to do so, we 

are supplementing the usual manual 

and electronic database searches of the 

literature by requesting information 

from the public (e.g., details of studies 

conducted). We are looking for studies 

that report on The Performance of 

Fusion Procedures for Degenerative 

Disease of the Lumbar Spine. The entire 

research protocol is available online at: 

https://effectivehealthcare.ahrq.gov/ 

products/lumbar-spinal-fusion/protocol. 

This is to notify the public that the 

EPC Program would find the following 

information on The Performance of 

Fusion Procedures for Degenerative 

Disease of the Lumbar Spine helpful: 

D A list of completed studies that your 

organization has sponsored for this 

topic. In the list, please indicate 

whether results are available on 

ClinicalTrials.gov along with the 

ClinicalTrials.gov trial number. 

D For completed studies that do not 

have results on ClinicalTrials.gov, a 

summary, including the following 

elements, if relevant: study number, 

study period, design, methodology, 

indication and diagnosis, proper use 

instructions, inclusion and exclusion 

criteria, primary and secondary 

outcomes, baseline characteristics, 

number of patients screened/eligible/ 

enrolled/lost to follow-up/withdrawn/ 

analyzed, effectiveness/efficacy, and 

safety results. 

D A list of ongoing studies that your 

organization has sponsored for this 

topic. In the list, please provide the 

ClinicalTrials.gov trial number or, if the 

trial is not registered, the protocol for 

the study including, if relevant, a study 

number, the study period, design, 

methodology, indication and diagnosis, 

proper use instructions, inclusion and 

exclusion criteria, and primary and 

secondary outcomes. 

D Description of whether the above 

studies constitute ALL Phase II and 

above clinical trials sponsored by your 

organization for this topic and an index 

outlining the relevant information in 

each submitted file. 

Your contribution is very beneficial to 

the Program. Materials submitted must 


khammond on DSK9W7S144PROD with NOTICES